AstraZeneca Profit Margin 2006-2020 | AZN

Current and historical gross margin, operating margin and net profit margin for AstraZeneca (AZN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AstraZeneca net profit margin as of March 31, 2020 is 5.94%.
AstraZeneca Annual Profit Margins
AstraZeneca Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $140.404B $24.384B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $387.206B 16.55
Roche Holding AG (RHHBY) Switzerland $300.991B 0.00
Pfizer (PFE) United States $212.084B 13.17
Merck (MRK) United States $199.505B 14.45
Novartis AG (NVS) Switzerland $197.737B 15.44
Novo Nordisk (NVO) Denmark $152.968B 25.48
Eli Lilly (LLY) United States $144.089B 23.32
Bristol-Myers Squibb (BMY) United States $135.331B 11.31
AbbVie (ABBV) United States $132.951B 9.76
Sanofi (SNY) $121.901B 14.11
GlaxoSmithKline (GSK) United Kingdom $104.204B 12.44
Bayer (BAYRY) Germany $64.271B 9.16
H Lundbeck (HLUYY) Denmark $7.655B 13.30
Innoviva (INVA) United States $1.455B 8.40